Episode 179 - Yawning in the Face of Sessions

Episode 179 – Yawning in the Face of Sessions

Betty Aldworth and Aaron Houston join host Kris Lotlikar to talk about the latest fallout of Attorney General Jeff Sessions rescinding the Cole Memo. Produced by Shea Gunther.   News & Links: • Vermont Gov. Scott confirms he will sign marijuana legalization bill | Cannabist • On Marijuana, Voters Want Feds To Butt Out Of […]

Episode 178 - Sessions Kills The Cole Memo

Episode 178 – Sessions Kills The Cole Memo

Dan Goldman, Adam Smith, and Alex Kreit join host Kris Lotlikar to talk about U.S. Attorney General Jeff Sessions and his rescinding of the Cole Memo, a DoJ guidance document protective of legal marijuana. Produced by Shea Gunther.   News & Links: • Vermont House votes to legalize marijuana | The Hill • Pennsylvania Gives […]

Episode 177 - A Look Back at 2017

Episode 177 – A Look Back at 2017

Hosts Kris Lotlikar, Kris Krane, and Dan Goldman talk about the biggest legal marijuana industry stories of 2017 and look ahead to what the New Year holds. Produced by Shea Gunther.   News & Links: • Jeff Sessions Leaves the Cole Memo Intact, For Now | Leafly • Rob Kampia Leaves Marijuana Policy Project | […]

Episode 176 - Coffeeshops in America

Episode 176 – Coffeeshops in America

Andrew Livingston, Betty Aldworth, Shea Gunther, and Jane West join hosts Kris Lotlikar and Dan Goldman to talk about the latest developments in the legalization of public social use, as well as some last-minute holiday gift ideas for the cannabis consumers in your life. Produced by Shea Gunther.   News & Links: • With New […]

Episode 175 - As Marijuana Rises, Alcohol Falls

Episode 175 – As Marijuana Rises, Alcohol Falls

Adam Smith and Scott Cecil join hosts Dan Goldman and Kris Lotlikar to talk about the efforts in Oregon to bring people into the legal cannabis market, the affects of legalization on alcohol sales, and the history of the Drug Reform Coordination Network’s “Drug War Chronicle”, which just published its 1,000th edition. Produced by Shea […]

Episode 174 - I Dream of California Cannabis

Episode 174 – I Dream of California Cannabis

Alex Kreit and Andrew Livingston joins host Kris Lotlikar to talk about how legal marijuana will be rolling out in California starting next month as well as a program to help state residents expunge cannabis crimes from their record. Produced by Shea Gunther.   News & Links: • Medical marijuana has arrived in Maryland, and […]

Episode 173 - California's New Cannabis Rules

Episode 173 – California’s New Cannabis Rules

Dan Goldman joins host Kris Lotlikar to talk about the new regulations proposed for California’s new legal marijuana markets as well as the influence and impact made on legal cannabis by former Congressman Maurice Hinchey, who passed away last week. Produced by Shea Gunther.   News & Links: • Did Past Harassment Allegations Finally Catch […]

Episode 172 - Nation of Second Chances

Episode 172 – Nation of Second Chances

Aaron Houston and Jon Perri join host Dan Goldman to talk about the latest comments made by Attorney General Jeff Sessions about the federal role in marijuana policy as well as Jon’s project, a Nation of Second Chances- Stories of Clemency. Produced by Shea Gunther.   News & Links: • MassRoots sues former CEO, alleges […]

Episode 171 - Marijuana's Election Night Run

Episode 171 – Marijuana’s Election Night Run

Taylor West, Andrew Livingston, and Shea Gunther join host Kris Krane to talk about how marijuana did in last week’s elections as well as the dimming prospects for Maine’s adult use commercial system. Produced by Shea Gunther.   News & Links: • Failed deal, red ink, dwindling sales put MassRoots on the ropes | Marijuana […]

sexytime bugs

Episode 170 – Cannabis Consumers Get Lucky (More Often)

Andrew Livingston and Scott Cecil join host Dan Goldman to talk about a recent study finding that regular cannabis consumers have sex more often than those who abstain, the huge acquisition of marijuana company Canopy Growth by alcohol giant Constellation Brands, as well as the recent crackdown by the U.S. FDA over health claims made […]